Amprion and Prema Cognition have entered into a collaboration to explore an approach for identifying and evaluating people…
Articles by Andrea Lobo
Blue light therapy delivered through Chrono Eyewear’s Propeaq glasses may help people with Parkinson’s disease sleep better and…
Gain Therapeutics’ oral therapy candidate rexaceract, formerly called GT-02287, stabilized motor symptoms in a small group of people with…
A team at Colorado State University (CSU) has been awarded $3 million from the National Institutes of Health (NIH) to…
AstronauTx has received $1.2 million in research funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)…
ACI-7104, AC Immune’s experimental vaccine for early Parkinson’s disease, was generally safe and triggered an immune response against…
A $2.5 billion fundraising campaign launched by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to accelerate the…
In a deal that could be worth more than $300 million, a Korean biotech has acquired exclusive global rights to…
A Parkinson’s disease therapy delivered through a wearable device eased motor function in some patients with advanced Parkinson’s, according…
A new clinical trial led by scientists at the Yale School of Medicine is testing whether targeting inflammation in people…